Palomino Laboratories (PALX) Total Current Liabilities (2022 - 2025)

Palomino Laboratories (PALX) reported Total Current Liabilities of $336458.0 for Q4 2025, up 5131.81% on a YoY basis from $6431.0 in Q4 2024, and down 66.32% sequentially from $999013.0 in Q3 2025.

Palomino Laboratories (PALX) Total Current Liabilities (2022 - 2025) Analysis & Trends

Palomino Laboratories (PALX) has 4 years of Total Current Liabilities data on file, last reported at $336458.0 in Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities rose 5131.81% year-over-year to $336458.0; the trailing twelve-month figure through Dec 2025 stood at $336458.0 (up 5131.81% YoY), and the FY2025 full-year result was $336458.0, up 5131.81% from the prior year.
  • Total Current Liabilities declined to $336458.0 in Q4 2025, from $999013.0 in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $999013.0 in Q3 2025 to a low of $6431.0 in Q4 2024.
  • A 4-year average of $258284.6 and a median of $194658.0 in 2024 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities sank 94.24% in 2024 and soared 5131.81% in 2025, its largest moves.
  • Tracing PALX's Total Current Liabilities over 4 years: stood at $27804.0 in 2022, then jumped by 301.46% to $111621.0 in 2023, then slumped by 94.24% to $6431.0 in 2024, then soared by 5131.81% to $336458.0 in 2025.
  • Business Quant data shows PALX's Total Current Liabilities at $336458.0 in Q4 2025, $999013.0 in Q3 2025, and $364431.0 in Q2 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 336,458.00
Sep 30, 2025 999,013.00
Jun 30, 2025 364,431.00
Mar 31, 2025 336,989.00
Dec 31, 2024 6,431.00
Sep 30, 2024 221,754.00
Jun 30, 2024 194,658.00
Mar 31, 2024 162,925.00
Dec 31, 2023 111,621.00
Sep 30, 2023 79,047.00
Dec 31, 2022 27,804.00